Investors can contact the law firm at no cost to learn more about recovering their losses
LOS ANGELES, Jan. 16, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Spectrum Pharmaceuticals, Inc. ("Spectrum" or the "Company") (NASDAQ: SPPI) investors that a lawsuit filed on behalf of investors that purchased securities Spectrum, Inc (NASDAQ: SPPI) between December 6, 2021 through September 22, 2022, inclusive (the ''Class Period'')
Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 844-767-8529 or email: lesley@portnoylaw.com, to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.
The complaint alleges that the defendants were conducting a clinical trial, called ZENITH20, which aimed to evaluate the effectiveness, safety, and tolerance of a drug called poziotinib for patients with a specific type of lung cancer. The defendants represented that the results from the trial were positive and that they were proceeding to the next phase of testing. However, a document from the FDA revealed that the safety and effectiveness of the drug was not as positive as the defendants claimed and that they had not enrolled any patients in the next phase of testing.
Please visit our website to review more information and submit your transaction information.
The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.
Lesley F. Portnoy, Esq.
Admitted CA and NY Bar
lesley@portnoylaw.com
310-692-8883
www.portnoylaw.com
Attorney Advertising
